Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Pancreatic Adenocarcinoma Metastatic × Decitabine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Leukemia, Myeloid, Acute 168 Myelodysplastic Syndromes 75 Leukemia 37 Leukemia, Myelomonocytic, Chronic 35 Recurrence 22 Myeloproliferative Disorders 14 Precursor Cell Lymphoblastic Leukemia-Lymphoma 13 Congenital Abnormalities 12 Lymphoma, Large B-Cell, Diffuse 11 Primary Myelofibrosis 8 Neoplasms 8 Blast Crisis 8 Thrombocythemia, Essential 7 Polycythemia Vera 7 Leukemia, Monocytic, Acute 7 Carcinoma, Non-Small-Cell Lung 7 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6 Myelodysplastic-Myeloproliferative Diseases 6 Melanoma 6 Leukemia, Myelomonocytic, Acute 6 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6 Hodgkin Disease 6 Anemia, Refractory, with Excess of Blasts 6 Ovarian Neoplasms 5 Leukemia, Myeloid, Accelerated Phase 5 Leukemia, Biphenotypic, Acute 5 Neoplasm Metastasis 4 Lymphoma, Non-Hodgkin 4 Lymphoma 4 Lung Neoplasms 4

Interventions

spartalizumab 1 sapropterin 1 penpulimab 1 niraparib 1 anlotinib 1 Taxes 1 Leucovorin 1 Ipilimumab 1 IFL protocol 1 Gemcitabine 1 Decitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05360264 2025-03-24

ORIENTATE

Regina Elena Cancer Institute

Phase 2 Terminated

Gastrointestinal

Pancreatic Adenocarcinoma Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡